Morning Buzz: KaloBios (KBIO), Can-Fite BioPharma (CANF), Amazon.com (AMZN), Apple (AAPL), eFuture Information Technology (EFUT)

KaloBios Pharmaceuticals, Inc. (KBIO) is up as much as 77% to $46.97 in pre-market trade on Friday after its CEO tweeted: “I spoke with my counsel & advisers and decided to stop lending my KBIO shares out until I better understand the advantages of doing so.” KaloBios has now seen its value surge by 2,500% in just a few days. The spike began on Nov. 19, when biotech investor Martin Shkreli announced a stake in the near-bankrupt biotechnology company. Shares were trading at less than 50 cents until couple of weeks ago.
—
Shares of Can-Fite BioPharma Ltd. (CANF) are higher by nearly 17% to $3.93 in pre-market trading on Friday following the company’s financial results for the nine months ended September 30, 2015 and updates on its drug development programs.
—
Shares of Amazon.com, Inc. (AMZN) were up slightly this morning on a Bloomberg report that the e-commerce giant might soon let viewers of its Prime Instant Video service to use other networks.
—
Apple Inc (AAPL) – TechChrunch details news that Cupertino has acquired “Faceshift”, a Swiss real-time motion capture startup that works on developing technology to create animated avatars and other figures that generate facial expressions that look human-like. Faceshift was used in the latest ‘Star Wars’ movie.
—
eFuture Information Technology Inc. (EFUT) shares spiked 154% to $20.75 in pre-market trading. With no specific news to account for the move, the strength is being attributed to Wednesday’s filing of 50.51% stake by Shiji (Hong Kong) Limited.

• Become A Funded Futures Trader